Health Trials

Sacituzumab Tirumotecan

1

Review clinical trials related to Sacituzumab Tirumotecan. Use filters to narrow results by trial status, phase, treatment, biological sex and sponsor.

Condition / disease
Location
Status: Not yet recruiting

Phase 2 Trial Of Sacituzumab Tirumotecan For Treatment Of Refractory Metastatic Or Unresectable Squamous Cell Carcinoma Of The Anus/Rectum

To look at the effectiveness of sacituzumab tirumotecan (MK-2870) in treating participants with treatment-refractory unresectable and/or metastatic anal/rectal cancer.

Participants needed: 20
Trial details
Phase: Phase 2Age: 18+Biological sex: AllType: InterventionalSponsor: M.D. Anderson Cancer CenterUpdated: Apr 6, 2026Locations: 1
Eligibility criteria

Participants must have histologically or cytologically confirmed squamous cell c... [+25]

Has a history of documented severe dry eye syndrome, severe Meibomian gland dise... [+21]

Read more